JHF, JFilm Partner to Raise Awareness of BRCA Cancer Risks, Treatment Options
September 20, 2016
Over the next year, the Jewish Healthcare Foundation will partner with JFilm and the producers of “Pink and Blue: Colors of Hereditary Cancer” to make the film available to audiences throughout the Pittsburgh region. The first film screening will be held during Breast Cancer Awareness Month on Thursday, October 13 at 7 pm at Magee-Womens Hospital of UPMC (Auditorium level).
“Pink and Blue” explores the clinical, social, and familial implications of BRCA1 and BRCA2 genetic mutations, which put both women and men at a higher risk of developing numerous cancers.
Without treatment, women who have a BRCA genetic mutation are seven times more likely to develop breast cancer and 30 times more likely to develop ovarian cancer by the age of 70, according to the Centers for Disease Control and Prevention. BRCA mutations may also increase the risk of pancreatic, prostate, and breast cancer among men. Ashkenazi Jews are at a higher risk of possessing BRCA genetic mutations than the general population.
To RSVP for the October 13 film screening, contact Administrative Coordinator Ben Johnston (firstname.lastname@example.org or 412-586-6714)
About The Jewish Healthcare Foundation
The Jewish Healthcare Foundation (JHF) is a public charity that offers a unique blend of research, education, grantmaking and program management to advance the quality of clinical care and health of populations, with a focus on improving the quality, efficiency, and safety of health care. JHF and its three operating arms—the Pittsburgh Regional Health Initiative (PRHI), Health Careers Futures (HCF), and the Women's Health Activist Movement Global (WHAMglobal)— are located in Pittsburgh, Pennsylvania, and serve a national and global audience. JHF is also a founding member of the Network for Regional Healthcare Improvement (NRHI). For more information, visit www.jhf.org.
Jewish Healthcare Foundation
412-594-2553 or 412-216-6305 (mobile)